V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007579 | 300004494 | null | 47.7 | Adjuvant (A) | 2015-10-16 | 2015-10-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 300016354 | FLUOROURACIL + MITOMYCIN |
| 300007580 | 300004495 | 1.69 | 60.6 | Palliative (P) | 2017-07-16 | 2018-01-14 | Folfirinox | Y | N | 300016364 | CARBOPLATIN + CETUXIMAB + FU |
| 300007581 | 300004499 | null | 64 | Curative (C) | 2013-10-16 | 2013-10-09 | Carboplatin AUC 6 - 10 | 02 | Y | 300016391 | CETUXIMAB |
| 300007582 | 300004501 | 1.55 | 110.4 | Palliative (P) | 2015-06-12 | 2015-06-20 | Docetaxel 75mg/m2 (21 day) | N | N | 300016399 | CETUXIMAB + RT |
| 300007583 | 300006869 | 1.55 | null | Palliative (P) | 2014-06-09 | 2014-06-09 | Carboplatin AUC 2 - 5 | 02 | N | 300016404 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300007584 | 300004504 | 1.59 | 58.6 | null | 2015-12-11 | 2015-12-12 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 300016413 | CAPECITABINE |
| 300007585 | 300004511 | 1.55 | 72.6 | Palliative (P) | null | 2013-11-12 | Gemcitabine + Oxaliplatin | N | N | 300016451 | CARBOPLATIN + DOCETAXEL |
| 300007586 | 300004516 | 1.52 | 58.5 | Curative (C) | 2014-10-11 | 2014-10-16 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 300016455 | TRIAL |
| 300007587 | 300004517 | 1.76 | null | null | 2017-10-09 | 2017-11-01 | CAPECITABINE + RT | Y | Y | 300016461 | CARBOPLATIN + RT |
| 300007588 | 300004522 | 1.55 | 73.5 | null | 2017-01-03 | 2017-03-30 | CETUXIMAB | N | N | 300016483 | DOCETAXEL |
| 300007589 | 300004525 | 1.85 | 84.6 | Palliative (P) | 2014-01-18 | 2014-01-19 | Trial Unspecified | N | N | 300016508 | CAPECITABINE + OXALIPLATIN |
| 300007590 | 300004526 | 1.73 | 62.2 | Curative (C) | 2013-11-29 | 2013-12-01 | Trial Unspecified | N | Y | 300016512 | CAPECITABINE + RT |
| 300007591 | 300004530 | 1.65 | 56.7 | Curative (C) | 2015-10-14 | 2015-10-07 | CAPECITABINE + OXALIPLATIN | 2 | N | 300016555 | GEMCITABINE + NAB-PACLITAXEL |
| 300007592 | 300004533 | 1.5 | 74.8 | Curative (C) | 2018-01-19 | 2018-02-26 | Carboplatin AUC 2 - 5 | null | Y | 300016575 | CISPLATIN + FLUOROURACIL |
| 300007593 | 300004537 | 1.53 | 55.5 | Curative (C) | 2016-06-26 | 2016-06-26 | Capecitabine + Oxaliplatin 21day | 2 | N | 300016596 | CAPECITABINE |
| 300007594 | 300004539 | 1.53 | 80.5 | Curative (C) | 2016-08-06 | 2017-09-04 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300016598 | CISPLATIN |
| 300007595 | 300004540 | 1.73 | 82 | Palliative (P) | 2013-03-26 | 2013-03-26 | Carboplatin AUC 6 - 10 | N | null | 300016605 | TRIAL |
| 300007596 | 300004541 | null | 76.1 | Curative (C) | 2013-04-10 | 2014-09-09 | Cetuximab 7 day (>Cycle 2) | N | Y | 300016607 | CARBOPLATIN + RT |
| 300007597 | 300004543 | 1.52 | null | Adjuvant (A) | 2013-11-24 | 2013-11-27 | Trial Unspecified | 2 | Y | 300016624 | CISPLATIN + FLUOROURACIL + RT |
| 300007598 | 300004545 | 1.74 | null | Palliative (P) | 2017-08-18 | 2017-08-18 | CARBOPLATIN + Cetuximab + FLUOROURACIL | Y | N | 300016626 | OXALIPLATIN + MDG |
| 300007599 | 300004547 | 1.81 | 46.3 | Palliative (P) | 2014-03-04 | 2014-04-27 | CETUXIMAB + RT | N | Y | 300016632 | CETUXIMAB + RT |
| 300007600 | 300004549 | null | 53.5 | Curative (C) | 2017-07-25 | 2017-08-08 | CAPECITABINE + OXALIPLATIN | 02 | Y | 300016636 | CETUXIMAB |
| 300007601 | 300004552 | 1.61 | null | Curative (C) | 2015-03-21 | 2015-11-10 | Cetuximab + Radiotherapy Maint | N | Y | 300016644 | CETUXIMAB + RT |
| 300007602 | 300004552 | 1.6 | 57.6 | Palliative (P) | 2014-05-26 | 2014-06-11 | FEC 60 or 75 | N | N | 300016644 | BEVACIZUMAB |
| 300007603 | 300004556 | 1.62 | 117 | Curative (C) | 2018-03-12 | 2018-08-14 | Capecitabine + Oxaliplatin 21day | N | N | 300016704 | CARBO + FLUOROURACIL |
| 300007604 | 300007758 | 0 | 129 | Palliative (P) | null | 2014-12-20 | PEMBROLIZUMAB | N | N | 300016712 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300007605 | 300004558 | 1.63 | 58 | Palliative (P) | 2017-10-08 | 2018-01-26 | Oxaliplatin + Modified de Gramont | N | N | 300016724 | CARBOPLATIN + CETUXIMAB + FU |
| 300007606 | 300004560 | 1.75 | 44.8 | Curative (C) | 2017-05-28 | 2017-08-09 | Cetuximab 7 day (>Cycle 2) | N | Y | 300016735 | CETUXIMAB + RT |
| 300007607 | 300004564 | 1.54 | null | Curative (C) | 2014-03-15 | 2014-03-18 | CAPECITABINE + RT | N | Y | 300016740 | CETUXIMAB + RT |
| 300007608 | 300004568 | 1.8 | 58.1 | Curative (C) | 2017-08-27 | 2017-09-08 | Cisplatin | N | Y | 300016750 | CISPLATIN |
| 300007609 | 300004569 | 1.43 | 63.3 | Palliative (P) | 2013-12-18 | 2013-12-18 | Gemcitabine + Capecitabine | N | N | 300016761 | BEVACIZUMAB |
| 300007610 | 300004571 | 1.63 | 79 | Palliative (P) | 2014-12-29 | 2014-12-31 | Capecitabine | 02 | N | 300016769 | ECARBOX |
| 300007612 | 300004577 | 1.67 | 95.2 | Neo-adjuvant (N) | 2016-12-08 | 2016-12-10 | Carboplatin AUC 6 - 10 | 02 | null | 300016805 | CARBOPLATIN |
| 300007613 | 300004580 | 1.85 | 68 | Neo-adjuvant (N) | 2015-11-22 | 2016-09-23 | BENDAMUSTINE + RITUXIMAB | 02 | N | 300016814 | TRIAL |
| 300007614 | 300004585 | 1.82 | null | Palliative (P) | 2013-10-31 | 2014-06-28 | Trial Unspecified | 02 | N | 300016838 | TRIAL |
| 300007615 | 300004588 | 1.6 | 67.5 | null | 2016-08-12 | 2016-08-12 | Cetuximab 7 day (>Cycle 2) | N | Y | 300016844 | CETUXIMAB + RT |
| 300007616 | 300004588 | 1.58 | 118.3 | Curative (C) | 2017-03-04 | 2017-03-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | 300016844 | CAPECITABINE + OXALIPLATIN |
| 300007617 | 300004590 | 1.67 | 53.5 | Curative (C) | 2015-03-03 | 2015-03-16 | CETUXIMAB | 2 | N | 300016855 | CISPLATIN + FLUOROURACIL |
| 300007619 | 300004595 | null | null | Curative (C) | 2019-02-26 | 2019-02-19 | Capecitabine | N | N | 300016876 | CARBOPLATIN |
| 300007620 | 300004597 | 1.64 | 63 | Palliative (P) | 2017-04-18 | 2017-05-04 | Capecitabine + Oxaliplatin 14day | 02 | N | 300016877 | CAPECITABINE + GEMCITABINE |
| 300007621 | 300004598 | 1.63 | 52 | Palliative (P) | 2016-10-29 | 2016-10-29 | FLUOROURACIL | N | N | 300016886 | LENALIDOMIDE |
| 300007622 | 300007763 | 1.61 | null | Palliative (P) | 2016-04-09 | 2016-04-10 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 300016941 | CYCLOPHOSPHAMIDE |
| 300007623 | 300004606 | 1.79 | null | Curative (C) | null | 2015-06-08 | ESPAC-4 TRIAL | 02 | null | 300016978 | OXALIPLATIN + MDG |
| 300007624 | 300004608 | 1.67 | 77 | Palliative (P) | 2015-05-10 | 2015-05-20 | Trial Unspecified | null | null | 300016983 | CISPLATIN |
| 300007625 | 300004611 | null | 72.6 | Curative (C) | 2016-04-29 | 2016-05-15 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300017004 | CISPLATIN + FLUOROURACIL |
| 300007626 | 300004615 | 1.6 | 70.9 | Neo-adjuvant (N) | null | 2016-09-26 | CARBOPLATIN + RT | null | null | 300017026 | OXALIPLATIN |
| 300007627 | 300004617 | 1.6 | 72.8 | Neo-adjuvant (N) | 2015-01-19 | 2015-03-13 | Carboplatin + Etoposide iv&po | 02 | N | 300017033 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007628 | 300004618 | 1.79 | 57.2 | Curative (C) | 2013-06-18 | 2014-10-04 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 2 | N | 300017043 | CISPLATIN + FLUOROURACIL |
| 300007629 | 300004626 | 1.67 | 59.2 | Neo-adjuvant (N) | 2019-05-01 | 2019-05-03 | VAI (Ifos 3g/m2) | null | null | 300017081 | ESPAC TRIAL |
| 300007630 | 300004628 | null | 101.7 | Neo-adjuvant (N) | 2017-02-02 | 2017-02-21 | NIVOLUMAB | N | N | 300017093 | NIVOLUMAB |